Atalanta Therapeutics Appoints Joanne Kotz as Chief Executive Officer and Douglas Pagán as Chief Financial Officer & Chief Operating Officer
Position
Chief Financial Officer
Company
Atalanta Therapeutics
BostonBiotechnologyHealth CareTherapeuticsDescription
Atalanta Therapeutics has named Joanne Kotz as Chief Executive Officer, succeeding Alicia Secor. The company also appointed Douglas Pagán as Chief Financial Officer & Chief Operating Officer, succeeding Jeffrey Young as part of a leadership transition.
Quick answer
Atalanta Therapeutics Appoints Joanne Kotz as Chief Executive Officer and Douglas Pagán as Chief Financial Officer & Chief Operating Officer (June 18, 2025). Atalanta Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Financial Officer at Atalanta Therapeutics?
- Atalanta Therapeutics named Douglas Pagán Chief Financial Officer, announced June 18, 2025.
- What did Atalanta Therapeutics announce on June 18, 2025?
- Atalanta Therapeutics has named Joanne Kotz as Chief Executive Officer, succeeding Alicia Secor. The company also appointed Douglas Pagán as Chief Financial Officer & Chief Operating Officer, succeeding Jeffrey Young as part of a leadership transition.
- What does Atalanta Therapeutics do?
- Atalanta Therapeutics is a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases.
- Where is Atalanta Therapeutics based?
- Atalanta Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- TOLREMO therapeutics (June 18, 2025), Alnylam Pharmaceuticals (June 19, 2025), Solu Therapeutics (June 16, 2025) and OnCusp Therapeutics (June 23, 2025) also announced leadership changes within 45 days of Atalanta Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- TOLREMO Appoints Florian D. Vogl as Chief Medical Officer (June 18, 2025)
- Alnylam Pharmaceuticals Appoints Pushkal Garg as Chief Research and Development Officer (June 19, 2025)
- Solu Therapeutics Appoints Enda Moran as Chief Operating Officer (June 16, 2025)
- OnCusp Therapeutics Appoints Dimitry S.A. Nuyten as Chief Medical Officer (June 23, 2025)
- Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer (June 23, 2025)
- Ascidian Therapeutics Appoints Murray A. Abramson as Chief Development Officer (June 24, 2025)
Who to call at Atalanta Therapeutics, and when
A new leader at Atalanta Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Atalanta Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Atalanta Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Atalanta Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Atalanta Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Atalanta Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.